Evidence map›Paper›PMID 24587380›Full record

ArticlePloS one2014

PRB1 is required for clipping of the histone H3 N terminal tail in Saccharomyces cerevisiae.

Yong Xue, Ajay A Vashisht, Yuliang Tan, Trent Su, James A Wohlschlegel

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Specific tracking of N-terminal clipping on histone H3 inMarine life science & technology · 2026
    Article
  2. Article
  3. Histone Tail Cleavage as a Mechanism for Epigenetic Regulation.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Vaccines · 2023
    Article
  7. Review
  8. Article
  9. Proteomic Analysis ofMolecules (Basel, Switzerland) · 2020
    Article
  10. Review
  11. Review
  12. Review
  13. Proteolysis suppresses spontaneous prion generation in yeast.The Journal of biological chemistry · 2017
    Article
  14. Article
  15. Functions for diverse metabolic activities in heterochromatin.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  16. Article
  17. Article
  18. Histone proteolysis: a proposal for categorization into 'clipping' and 'degradation'.BioEssays : news and reviews in molecular, cellular and developmental biology · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yong XueDepartment of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Ajay A VashishtDepartment of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Yuliang TanDepartment of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Trent SuDepartment of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
James A WohlschlegelDepartment of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
University of California, Los Angeles · US

Funding

CONTROL OF HISTONE FUNCTION IN YEASTR37GM023674 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GRUNSTEIN, MICHAEL · 1998 to 2007
$4.7M
CHROMOSOMAL REPRESSION OF YEAST HETEROCHROMATINR01GM042421 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GRUNSTEIN, MICHAEL · 1989 to 2010
$4.4M
Proteolytic Control of Iron Metabolism by the Ubiquitin Ligase FBXL5R01GM089778 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WOHLSCHLEGEL, JAMES AKIRA · 2010 to 2023
$4.0M
GENETIC AND BIOCHEMICAL APPROACH TO HISTONE FUNCTIONR01GM023674 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GRUNSTEIN, MICHAEL · 1985 to 2011
$2.6M
NIGMS NIH HHS GM23674NIGMS NIH HHS GM42421NIGMS NIH HHS R01 GM023674NIGMS NIH HHS R01 GM042421NIGMS NIH HHS R01 GM089778NIGMS NIH HHS R37 GM023674
6 · The paper itself

Abstract

Cathepsin L, a lysosomal protein in mouse embryonic stem cells has been shown to clip the histone H3 N- terminus, an activity associated with gene activity during mouse cell development. Glutamate dehydrogenase (GDH) was also identified as histone H3 specific protease in chicken liver, which has been connected to gene expression during aging. In baker's yeast, Saccharomyces cerevisiae, clipping the histone H3 N-terminus has been associated with gene activation in stationary phase but the protease responsible for the yeast histone H3 endopeptidase activity had not been identified. In searching for a yeast histone H3 endopeptidase, we found that yeast vacuolar protein Prb1 is present in the cellular fraction enriched for the H3 N-terminus endopeptidase activity and this endopeptidase activity is lost in the PRB1 deletion mutant (prb1Δ). In addition, like Cathepsin L and GDH, purified Prb1 from yeast cleaves H3 between Lys23 and Ala24 in the N-terminus in vitro as shown by Edman degradation. In conclusion, our data argue that PRB1 is required for clipping of the histone H3 N-terminal tail in Saccharomyces cerevisiae.

Indexed as

AlanineBlotting, WesternEndopeptidasesHistonesLysineMass SpectrometryMutationSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAlanineEndopeptidasesHistonesLysinePRB1 protein, S cerevisiaeSaccharomyces cerevisiae Proteins

Identifiers

PMID24587380
PMCPMC3938757
OpenAlexW2094813903

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.